Literature DB >> 11201642

A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease.

D H Han1, O K Kwon, B J Byun, B Y Choi, C W Choi, J U Choi, S G Choi, J O Doh, J W Han, S Jung, S D Kang, D J Kim, H I Kim, H D Kim, M C Kim, S C Kim, S C Kim, Y Kim, B D Kwun, B G Lee, Y J Lim, J G Moon, H S Park, M S Shin, J H Song, J S Suk, M B Yim.   

Abstract

A co-operative study was conducted to determine the clinical characteristics of patients with moyamoya disease who were diagnosed and treated at neurosurgical institutes in Korea before 1995. Twenty-six hospitals contributed 505 cases and among them, the clinical characteristics of 334 patients with definite moyamoya disease were evaluated. The number of patients began to increase from the late 1980s, and after that approximately 20 patients were treated each year. There were two age peaks: from six to 15 and from 31 to 40 years of age. Haemorrhagic manifestations occurred in approximately 43% of the patients. The major clinical manifestations were haemorrhage in adults (62.4%) and ischaemia in children (61.2%). Overall 54.5% of the patients experienced decreased consciousness levels, mainly due to intracranial haemorrhage or cerebral infarction. In the patients with ischemic manifestations, the adult patients were more likely to have cerebral infarction than the pediatric patients (80% vs. 39%) and the pediatric patients were more likely to have TIA (61% vs. 25%). Thirty eight percent of the patients underwent bypass surgery and 53% of these procedures were performed bilaterally. Treatment policies, including indications for bypass surgery and commonly used drugs, were somewhat different according to the institution. Overall favorable outcome was 73%, and the most significant factor affecting poor outcome was haemorrhagic manifestation. This article describes the characteristics of 334 patients with moyamoya disease, who were diagnosed and treated at neurosurgical institutes in Korea before 1995.

Entities:  

Mesh:

Year:  2000        PMID: 11201642     DOI: 10.1007/s007010070024

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  26 in total

Review 1.  The promotion of pediatric neurosurgery throughout the world.

Authors:  Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-09       Impact factor: 1.475

2.  Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.

Authors:  M K Strother; M D Anderson; R J Singer; L Du; R D Moore; Y Shyr; T R Ladner; D Arteaga; M A Day; P F Clemmons; M J Donahue
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

3.  Missing relationship of moyamoya and persistent primitive artery in Europeans. Another distinctive feature or artifact?

Authors:  Holger Wenz; Ralf Wenz; Alex Förster; Johann Fontana; Hans Ulrich Kerl; Christoph Groden; Johann Scharf
Journal:  Surg Radiol Anat       Date:  2015-03-08       Impact factor: 1.246

4.  Surgical management of moyamoya syndrome.

Authors:  Edward R Smith; R Michael Scott
Journal:  Skull Base       Date:  2005-02

Review 5.  Inherited neurovascular diseases affecting cerebral blood vessels and smooth muscle.

Authors:  Christine Sam; Fei-Feng Li; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2015-04-21       Impact factor: 3.584

6.  Clinical and angiographic features and stroke types in adult moyamoya disease.

Authors:  D-K Jang; K-S Lee; H K Rha; P-W Huh; J-H Yang; I S Park; J-G Ahn; J H Sung; Y-M Han
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-02       Impact factor: 3.825

7.  Moyamoya disease in which pentazocine treatment caused cerebral infarction.

Authors:  Yoshinori Matsuoka; Makoto Hashizume
Journal:  BMJ Case Rep       Date:  2010-11-09

Review 8.  Pediatric moyamoya disease: clinical profile, literature review and sixteen year experience from a tertiary care teaching institute.

Authors:  Pratibha Singhi; Anita Choudhary; Niranjan Khandelwal
Journal:  Indian J Pediatr       Date:  2013-03-24       Impact factor: 1.967

Review 9.  Moyamoya disease: a clinical spectrum, literature review and case series from a tertiary care hospital in Pakistan.

Authors:  Sana Shoukat; Ahmed Itrat; Ather M Taqui; Moazzam Zaidi; Ayeesha K Kamal
Journal:  BMC Neurol       Date:  2009-04-15       Impact factor: 2.474

10.  Moyamoya disease presented as a case of hemiplegic migraine.

Authors:  M R Siddiqui; S U Khan; M A Hoque; K M Rahman; M B A Mondol; Q D Mohammad
Journal:  BMJ Case Rep       Date:  2010-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.